Our results show that the change of NRAV expression can significantly affect the ferroptosis-related proteins SLC7A11, GPX4, and ACSL4, especially SLC7A11, and can change the Fe2+ content and ROS level in HCC cells. Here, ACSL4 is linked to hepatocellular carcinoma.